$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is Mobotinib (Mobosetinib) a targeted drug for lung cancer that needs to be taken long-term?
2026-02-01 22:25:32
Check Details
Mobotinib: a new lung cancer drug that precisely targets EGFR exon 20 insertion mutations
2026-02-01 22:25:32
Check Details
Mobotinib (Mobosetinib) Hong Kong version original drug price and purchasing guide
2026-02-01 22:25:32
Check Details
Mobotinib (Mobosetinib) Generic Drug Price and Buying Guide
2026-02-01 22:25:32
Check Details
Market overview and buying guide of ibrutinib/ibrutinib
2026-02-01 22:25:32
Check Details
What are the advantages of ibrutinib/ibrutinib Bangladesh version?
2026-02-01 22:25:32
Check Details
What are the common side effects of ibrutinib/ibrutinib and how should they be dealt with?
2026-02-01 22:25:32
Check Details
Obeticholic acid drug information and correct usage
2026-02-01 22:25:32
Check Details
Indian version of obeticholic acid generic drug purchasing channels and latest price information
2026-02-01 22:25:32
Check Details
Detailed explanation of obeticholic acid applicable groups and precautions
2026-02-01 22:25:32
Check Details
What drug is Imetelstat?
2026-02-01 22:25:32
Check Details
What diseases does Imetelstat treat?
2026-02-01 22:25:32
Check Details
1
2
...
965
966
967
968
969
970
971
...
10223
10224
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tazemetostat Dosage Guide: Laos Generic vs. Original Tazverik Comparison
2
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
3
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
4
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons
5
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
6
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison
7
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
8
Elagolix Side Effects and Safety Guide
9
Hetrombopag vs. Avatrombopag: Key Differences Between Two Oral TPO-RAs and Safety Considerations
10
Lytenava: The First FDA-Approved Ophthalmic Bevacizumab Formulation
11
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
12
Simtriyo (Centanafadine): World's First NDSRI ADHD Drug Approved by FDA